Tyson Foods, Inc.NYSE: TSN

Tyson Foods Reports Fourth Quarter 2026 Results

· Issued by Tyson Foods, Inc.

Key figures

  • GAAP operating income of $1,100 million, flat from prior year
  • Adjusted operating income of $1,977 million, down 14% from prior year
  • GAAP EPS of $1.28, down 4% from prior year
  • Adjusted EPS of $3.44, down 17% from prior year
  • Total Company GAAP operating margin of 1.9%

On 6ix: 6ix.com/news/tyson-foods-reports-fourth-quarter-2026-results

TYSON FOODS REPORTS FOURTH QUARTER AND FISCAL 2026 RESULTS

Prepared Foods Growth and Chicken Resilience Bolster Performance

Springdale, Arkansas - November 16, 2026 - Tyson Foods, Inc. (NYSE: TSN), one of the world's largest food companies and a recognized leader in protein with leading brands including Tyson, Jimmy Dean, Hillshire Farm, Ball Park, Wright, State Fair, aidells and ibp reported the following results:

(in millions, except per share data) Fourth Quarter Twelve Months Ended

2026

2025

2026

2025

Sales

$ 14,585

$ 13,860

$ 56,419

$ 54,441

Adjusted Sales (non-GAAP)1

$ 13,536

$ 13,860

$ 55,370

$ 54,441

Operating Income

$ 1

$ 158

$ 1,100

$ 1,098

Adjusted Operating Income (non-GAAP)1

$ 361

$ 608

$ 1,977

$ 2,287

Net Income (Loss) Per Share Attributable to Tyson

$ (0.22)

$ 0.13

$ 1.28

$ 1.33

Adjusted Net Income Per Share Attributable to Tyson (non-GAAP)1

$ 0.61

$ 1.15

$ 3.44

$ 4.12

1 The Company reports its financial results in accordance with U.S. generally accepted accounting principles (GAAP). As used in this table and throughout this earnings release, adjusted sales (due to the impact of an additional week in the fourth quarter of fiscal 2026), adjusted operating income (loss), adjusted net income per share attributable to Tyson (Adjusted EPS), segment operating income (loss), as adjusted, corporate expenses, as adjusted, amortization, as adjusted, and free cash flow are non-GAAP financial measures. Adjusted sales, adjusted operating income and adjusted EPS for the fourth quarter and twelve months of fiscal 2026 are presented on a 13-week and 52-week basis, respectively. Refer to the end of this release for an explanation and reconciliation of these and other non-GAAP financial measures used in this release to comparable GAAP measures.

Fiscal 2026 Highlights

  • Sales of $56,419 million, up 3.6% compared to prior year; Sales up 1.1% excluding the additional week in fiscal 2026 and legal contingency accruals recognized as reductions to Sales of $358 million and $698 million in the current and prior years, respectively

  • GAAP operating income of $1,100 million, flat from prior year

  • Adjusted operating income of $1,977 million, down 14% from prior year

  • GAAP EPS of $1.28, down 4% from prior year

  • Adjusted EPS of $3.44, down 17% from prior year

  • Total Company GAAP operating margin of 1.9%

  • Total Company adjusted operating margin (non-GAAP) of 3.5%

  • Liquidity of $4.1 billion as of October 3, 2026

  • Cash provided by operating activities of $2,433 million, up $278 million from prior year

  • Free cash flow (non-GAAP) of $1,663 million, up $486 million from prior year

  • Reduced total debt $1,080 million

  • Repurchased 7.8 million shares for $427 million

    Fourth Quarter Highlights

  • Sales of $14,585 million, up 5.2% compared to prior year; Sales down 4.0% excluding the additional week in fiscal 2026 and legal contingency accruals recognized as reductions to Sales of $110 million and $355 million in the current and prior years, respectively

  • GAAP operating income of $1 million, down $157 million from prior year

  • Adjusted operating income of $361 million, down 41% from prior year

  • GAAP EPS of ($0.22), down $0.35 from prior year

  • Adjusted EPS of $0.61, down 47% from prior year

  • Total Company GAAP operating margin was approximately zero

  • Total Company adjusted operating margin (non-GAAP) of 2.6%

"Our performance in fiscal 2026 reflects the strength of our diversified multiprotein model and our dedication to our customers and consumers," said Jeff Schomburger, President and CEO of Tyson Foods. "We'll build on those strengths through investment in our brands, innovation and operating capabilities, while remaining focused on the returns those investments can deliver alongside market conditions. As we look ahead, our priorities are clear: earn consumer preference and be indispensable to our customers."

SEGMENT RESULTS (in millions)2

Sales

(for the fourth quarter and twelve months ended October 3, 2026, and September 27, 2025)

Fourth Quarter

Twelve Months Ended

2026 2025

Volume

Change

Avg. Price

Change3

2026

2025

Volume

Change

Avg. Price

Change3

Beef

$ 5,295 $ 5,489

(6.0) %

0.4 %

$ 21,662

$ 21,623

(10.6) %

10.2 %

Pork

1,560 1,414

15.3 %

(13.6) %

6,328

5,781

6.3 %

(2.5) %

Chicken

4,811 4,411

9.9 %

(0.8) %

17,564

16,837

4.1 %

0.8 %

Prepared Foods

2,754 2,546

7.4 %

0.8 %

10,495

9,930

2.0 %

3.7 %

International

667 584

8.9 %

5.3 %

2,427

2,291

0.9 %

5.0 %

Intersegment Sales

(502) (584)

n/a

n/a

(2,057)

(2,021)

n/a

n/a

Total

$ 14,585 $ 13,860

6.8 %

(3.4)%

$ 56,419

$ 54,441

0.3 %

2.7 %

Segment Operating Income (Loss), As Reported

(for the fourth quarter and twelve months ended October 3, 2026, and September 27, 2025)

Fourth Quarter

Twelve Months Ended

2026 2025

Operating Margin

2026 2025

2026 2025

Operating Margin

2026 2025

Beef

$ (514) $ (277)

(9.7) %

(5.0) %

$ (1,215) $ (984)

(5.6) %

(4.6) %

Pork

(14) (83)

(0.9) %

(5.9) %

137 (141)

2.2 %

(2.4) %

Chicken

405 558

8.4 %

12.7 %

1,749 1,860

10.0 %

11.0 %

Prepared Foods

344 232

12.5 %

9.1 %

1,326 1,248

12.6 %

12.6 %

International

52 1

7.8 %

0.2 %

179 155

7.4 %

6.8 %

Total Segment Operating Income, As Reported

$ 273 $ 431

1.9 %

3.1 %

$ 2,176 $ 2,138

3.9 %

3.9 %

Corporate Expenses

$ (214) $ (209)

n/a

n/a

$ (856) $ (783)

n/a

n/a

Amortization

(58) (64)

n/a

n/a

(220) (257)

n/a

n/a

Operating Income

$ 1 $ 158

- %

1.1 %

$ 1,100 $ 1,098

1.9 %

2.0 %

ADJUSTED SEGMENT RESULTS (in millions)2

Adjusted Sales (Non-GAAP)1,4

(for the fourth quarter and twelve months ended October 3, 2026, and September 27, 2025)

Fourth Quarter

Twelve Months Ended

2026 2025

Adjusted

Volume Change

Adjusted

Avg. Price Change3

2026

2025

Adjusted

Volume Change

Adjusted

Avg. Price Change3

Beef

$ 4,910 $ 5,489

(12.7) %

0.4 %

$ 21,277

$ 21,623

(12.2) %

10.0 %

Pork

1,448 1,414

7.0 %

(12.6) %

6,216

5,781

4.4 %

(2.4) %

Chicken

4,468 4,411

2.0 %

(0.7) %

17,221

16,837

2.1 %

0.8 %

Prepared Foods

2,557 2,546

(0.3) %

0.7 %

10,298

9,930

0.1 %

3.6 %

International

619 584

1.1 %

5.0 %

2,379

2,291

(1.0) %

4.9 %

Intersegment Sales

(466) (584)

n/a

n/a

(2,021)

(2,021)

n/a

n/a

Total

$ 13,536 $ 13,860

(0.8)%

(3.2)%

$ 55,370

$ 54,441

(1.6)%

2.7 %

Segment Operating Income (Loss), As Adjusted (Non-GAAP)1,4

(for the fourth quarter and twelve months ended October 3, 2026, and September 27, 2025)

Fourth Quarter

Twelve Months Ended

20264 2025

Adjusted Operating Margin (Non-GAAP)

20263 20253

2026 2025

Adjusted Operating Margin (Non-GAAP)

20263 20253

Beef

$ (171) $ (52)

(3.4) %

(0.9) %

$ (654) $ (275)

(3.0) %

(1.3) %

Pork

16 47

1.1 %

3.0 %

228 239

3.6 %

3.9 %

Chicken

389 562

8.7 %

12.7 %

1,859 1,892

10.7 %

11.2 %

Prepared Foods

321 278

12.6 %

10.9 %

1,332 1,263

12.9 %

12.7 %

International

49 40

7.9 %

6.8 %

180 185

7.6 %

8.1 %

Total Segment Operating Income, As Adjusted

$ 604 $ 875

4.4 %

6.2 %

$ 2,945 $ 3,304

5.3 %

6.0 %

Corporate Expenses, As Adjusted (Non-GAAP)1

$ (189) $ (209)

n/a

n/a

$ (752) $ (783)

n/a

n/a

Amortization, As Adjusted (Non-GAAP)1

(54) (58)

n/a

n/a

(216) (234)

n/a

n/a

Adjusted Operating Income (Non-GAAP)1

$ 361 $ 608

2.6 %

4.3 %

$ 1,977 $ 2,287

3.5 %

4.1 %

2 Commencing in the first quarter of fiscal 2026, the Company no longer allocates corporate expenses and amortization to segments as these items are no longer used in assessing the performance of, or in allocating resources to, the segments. Accordingly, the Company changed its segment reporting to separately disclose corporate expenses and amortization from its reportable segments and identified International as a reportable segment. All prior period amounts have been recast to reflect the new presentation of segment operating income (loss).

3 Average Price Change, Adjusted Average Price Change and Adjusted Operating Margin (Non-GAAP) for the Beef and Pork segments and Total Company for the three months ended October 3, 2026 exclude the impact of $100 million, $10 million and $110 million, respectively, of legal contingency accruals recognized as a reduction to Sales. Adjusted Average Price Change and Adjusted Operating Margin (Non-GAAP) for the Beef, Pork and Chicken segments and Total Company for the twelve months ended October 3, 2026 exclude the impact of $190 million, $70 million, $98 million and $358 million, respectively, of legal contingency accruals recognized as reductions to Sales. Adjusted Average Price Change and Adjusted Operating Margin (Non-GAAP) for the Beef and Pork segments and Total Company for the three months ended September 27, 2025 exclude the impact of $225 million, $130 million and $355 million, respectively, of legal contingency accruals recognized as a reduction to Sales. Adjusted Average Price Change and Adjusted Operating Margin (Non-GAAP) for the Beef and Pork segments and Total Company for the twelve months ended September 27, 2025 exclude the impact of $318 million, $380 million and $698 million, respectively, of legal contingency accruals recognized as reductions to Sales.

4 Adjusted Sales, Adjusted Volume Change, Adjusted Average Price Change, Segment Operating Income (Loss), As Adjusted, Adjusted Operating Income (Loss) and Adjusted Operating Margin for the three months ended October 3, 2026 and the twelve months ended October 3, 2026 are presented on a 13-week and 52-week basis, respectively.

OUTLOOK

For fiscal 2027, the United States Department of Agriculture (USDA) indicates domestic protein production (beef, pork, chicken and turkey) will be flat to a slight increase compared to fiscal 2026 levels. The following is a summary of the outlook for each of our segments, as well as an outlook for corporate expenses and amortization, revenue, capital expenditures, net interest expense, liquidity, free cash flow, tax rate and dividends for fiscal 2027. As our accounting cycle resulted in a 53-week year in fiscal 2026 as compared to a 52-week year in fiscal 2027, percentage changes presented below for fiscal 2027, other than USDA projections, are shown in comparison to fiscal 2026 results as adjusted to a comparable 52-week basis. Certain of the outlook numbers include adjusted operating income (loss) and segment operating income (loss), as adjusted, and free cash flow which are non-GAAP measures. The Company is not able to reconcile its full-year fiscal 2027 projected adjusted results to its fiscal 2027 projected GAAP results because certain information necessary to calculate such measures on a GAAP basis is unavailable or dependent on the timing of future events outside of our control. Therefore, because of the uncertainty and variability of the nature of and the amount of any potential applicable future adjustments, which could be significant, the Company is unable to provide a reconciliation for these forward-looking non-GAAP measures without unreasonable effort. Adjusted operating income (loss), segment operating income (loss), as adjusted, and free cash flow should not be considered substitutes for operating income (loss), cash provided by operating activities or any other measures of financial performance reported in accordance with GAAP. Investors should rely primarily on the Company's GAAP results and use non-GAAP financial measures only supplementally in making investment decisions.

Beef

USDA projects domestic production will decrease approximately 2% in fiscal 2027 as compared to fiscal 2026. We anticipate segment operating income (loss), as adjusted, of $(300) million to $100 million in fiscal 2027.

Pork

USDA projects domestic production will be relatively flat in fiscal 2027 as compared to fiscal 2026. We anticipate segment operating income, as adjusted, of $75 million to $175 million in fiscal 2027.

Chicken

USDA projects chicken production will increase approximately 1% in fiscal 2027 as compared to fiscal 2026. We anticipate segment operating income, as adjusted, of $1.3 billion to $1.6 billion in fiscal 2027.

Prepared Foods

We anticipate segment operating income, as adjusted, of $1.25 billion to $1.4 billion in fiscal 2027.

International

We anticipate segment operating income, as adjusted, of $125 million to $200 million in fiscal 2027.

Corporate Expenses and Amortization

We anticipate corporate expenses and amortization, as adjusted, of approximately $1.0 billion in fiscal 2027.

Total Company

We anticipate total company adjusted operating income of $1.7 billion to $2.15 billion for fiscal 2027.

Revenue

We expect sales to decrease 3.5% to 5.5% in fiscal 2027 as compared to fiscal 2026, primarily due to lower Beef segment volumes resulting from our network restructuring and tight cattle supplies.

Capital Expenditures

We expect capital expenditures between $1.1 billion to $1.4 billion in fiscal 2027. Capital expenditures include investments in profit improvement projects as well as projects for maintenance and repairs.

Net Interest Expense

We expect net interest expense to approximate $360 million in fiscal 2027.

Liquidity

We expect total liquidity, which was $4.1 billion as of October 3, 2026, to remain well above our minimum liquidity target of $1.0 billion.

Free Cash Flow

We expect free cash flow to be between $0.8 billion and $1.3 billion for fiscal 2027.

Tax Rate

We currently expect our adjusted effective tax rate to approximate 25% in fiscal 2027.

Dividends

Effective November 13, 2026, the Board of Directors increased the quarterly dividend previously declared on August 6, 2026, to $0.52 per share on our Class A common stock and $0.468 per share on our Class B common stock. The increased quarterly dividend is payable on December 15, 2026, to shareholders of record at the close of business on December 1, 2026. The Board also declared on November 13, 2026, a quarterly dividend of $0.52 per share on our Class A common stock and $0.468 per share on our Class B common stock, payable on March 15, 2027, to shareholders of record at the close of business on March 1, 2027. We anticipate the remaining quarterly dividends in fiscal 2027 will be $0.52 and $0.468 per share of our Class A and Class B common stock, respectively. This results in an annual dividend rate in fiscal 2027 of $2.08 for Class A shares and $1.872 for Class B shares, or a 2% increase compared to the fiscal 2026 annual dividend rate.

CONSOLIDATED CONDENSED STATEMENTS OF INCOME

(In millions, except per share data) (Unaudited)

Three Months Ended Twelve Months Ended

October 3, 2026

September 27, 2025

October 3, 2026

September 27, 2025

Sales

$ 14,585

$ 13,860

$ 56,419

$ 54,441

Cost of Sales

14,046

13,134

53,189

50,879

Gross Profit

539

726

3,230

3,562

Selling, General and Administrative

538

568

2,130

2,121

Goodwill Impairment

-

-

-

343

Operating Income

Other (Income) Expense:

1

158

1,100

1,098

Interest income

(10)

(16)

(37)

(73)

Interest expense

107

106

406

449

Other, net

(13)

-

62

(47)

Total Other (Income) Expense

84

90

431

329

Income (Loss) before Income Taxes

(83)

68

669

769

Income Tax Expense (Benefit)

(16)

10

196

262

Net Income (Loss)

(67)

58

473

507

Less: Net Income Attributable to Noncontrolling Interests

7

11

20

33

Net Income (Loss) Attributable to Tyson

$ (74)

$ 47

$ 453

$ 474

Net Income (Loss) Per Share Attributable to Tyson:

Class A Basic

$ (0.22)

$ 0.14

$ 1.31

$ 1.37

Class B Basic

$ (0.20)

$ 0.12

$ 1.18

$ 1.22

Diluted

$ (0.22)

$ 0.13

$ 1.28

$ 1.33

Dividends Declared Per Share:

Class A

$ 0.510

$ 0.500

$ 2.050

$ 2.010

Class B

$ 0.459

$ 0.450

$ 1.845

$ 1.809

Sales Growth

5.2 %

3.6 %

Margins (Percent of Sales):

Gross Profit

3.7 %

5.2 %

5.7 %

6.5 %

Operating Income

- %

1.1 %

1.9 %

2.0 %

Net Income (Loss) Attributable to Tyson

(0.5)%

0.3 %

0.8 %

0.9 %

Effective Tax Rate5

19.0 %

14.4 %

29.3 %

34.1 %

5 The effective tax rate for the twelve months ended October 3, 2026 is impacted by an $83 million executive leadership transition charge that is non-deductible for income tax purposes. The effective tax rate for the twelve months ended September 27, 2025 is impacted by a $343 million goodwill impairment charge that is non-deductible for income tax purposes.

CONSOLIDATED CONDENSED BALANCE SHEETS

(In millions) (Unaudited)

October 3, 2026

September 27, 2025

Assets

Current Assets:

Cash and cash equivalents

$ 824

$ 1,229

Accounts receivable, net

2,365

2,524

Inventories

5,578

5,681

Other current assets

555

482

Total Current Assets

9,322

9,916

Net Property, Plant and Equipment

8,561

9,204

Goodwill

9,469

9,469

Intangible Assets, net

5,421

5,624

Other Assets

2,333

2,445

Total Assets

$ 35,106

$ 36,658

Liabilities and Shareholders' Equity

Current Liabilities:

Current debt

$ 848

$ 909

Accounts payable

3,047

2,601

Other current liabilities

2,337

2,879

Total Current Liabilities

6,232

6,389

Long-Term Debt

6,902

7,921

Deferred Income Taxes

2,214

2,195

Other Liabilities

2,039

1,926

Total Tyson Shareholders' Equity

17,614

18,085

Noncontrolling Interests

105

142

Total Shareholders' Equity

17,719

18,227

Total Liabilities and Shareholders' Equity

$ 35,106

$ 36,658

CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS

(In millions) (Unaudited)

Twelve Months Ended

October 3, 2026

September 27, 2025

Cash Flows From Operating Activities:

Net income

$ 473

$ 507

Depreciation and amortization

1,398

1,361

Deferred income taxes

3

(76)

Impairment of goodwill

-

343

Gain on sale of storage facilities

-

(107)

Other, net

515

233

Net changes in operating assets and liabilities

44

(106)

Cash Provided by Operating Activities

2,433

2,155

Cash Flows From Investing Activities:

Additions to property, plant and equipment

(770)

(978)

Purchases of marketable securities

(58)

(66)

Proceeds from sale of marketable securities

85

62

Proceeds from sale of storage facilities

44

252

Proceeds from sale of equity investments

84

-

Acquisition of equity investments

-

(11)

Other, net

73

76

Cash Used for Investing Activities

(542)

(665)

Cash Flows From Financing Activities:

Proceeds from issuance of debt

1,597

175

Payments on debt

(2,745)

(1,262)

Proceeds from issuance of commercial paper

945

-

Repayments of commercial paper

(945)

-

Purchases of Tyson Class A common stock

(414)

(196)

Dividends

(704)

(697)

Stock options exercised

27

21

Other, net

(69)

(18)

Cash Used for Financing Activities

(2,308)

(1,977)

Effect of Exchange Rate Changes on Cash

12

(1)

Decrease in Cash and Cash Equivalents

(405)

(488)

Cash and Cash Equivalents at Beginning of Year

1,229

1,717

Cash and Cash Equivalents at End of Period

$ 824

$ 1,229

Non-GAAP Financial Measures

Adjusted Sales (due to the impact of an additional week in the fourth quarter of fiscal 2026), Adjusted Operating Income (Loss), Adjusted Income before Income Taxes, Adjusted Income Tax Expense, Adjusted Net Income Attributable to Tyson and Adjusted EPS, EBITDA, Adjusted EBITDA, net debt to EBITDA, net debt to Adjusted EBITDA, Segment Operating Income (Loss), As Adjusted, Corporate Expenses, As Adjusted, Amortization, As Adjusted, and Free Cash Flow are presented as supplemental financial measures in the evaluation of our business that are not required by, or presented in accordance with GAAP. The non-GAAP financial measures are tools intended to assist our management and investors in comparing our performance on a consistent basis for purposes of business decision-making by removing the impact of certain items that management believes do not directly reflect our core operations on an ongoing basis. These non-GAAP measures should not be a substitute for their comparable GAAP financial measures. Investors should rely primarily on our GAAP results and use non-GAAP financial measures only supplementally in making investment decisions. We believe the presentation of these non-GAAP financial measures helps management and investors to assess our operating performance from period to period, including our ability to generate earnings sufficient to service our debt, enhances understanding of our financial performance and highlights operational trends. These measures are widely used by investors and rating agencies in the valuation, comparison, rating and investment recommendations of companies. Our calculation of non-GAAP measures may not be comparable to similarly titled measures reported by other companies and other companies may not define these non-GAAP financial measures in the same way, which may limit their usefulness as comparative measures.

Definitions

EBITDA is defined as net income (loss) before interest, income taxes, depreciation and amortization. Net debt to EBITDA (Adjusted EBITDA) represents the ratio of our debt, net of cash, cash equivalents and short-term investments, to EBITDA (and to Adjusted EBITDA). EBITDA, Adjusted EBITDA, net debt to EBITDA and net debt to Adjusted EBITDA are presented as supplemental financial measurements in the evaluation of our business.

Adjusted EBITDA, Adjusted Operating Income (Loss), Adjusted Income before Income Taxes, Adjusted Income Tax Expense, Adjusted Net Income Attributable to Tyson and Adjusted EPS are defined as EBITDA, Operating Income (Loss), Income (Loss) before Income Taxes, Income Tax Expense (Benefit), Net Income (Loss) Attributable to Tyson and diluted earnings per share, respectively, excluding the impacts of any items that management believes do not directly reflect our core operations on an ongoing basis, as well as the impact of an additional week in fiscal 2026.

Adjusted Sales is defined as reported Sales excluding the impact of the additional week in the fourth quarter of fiscal 2026. The impact of the additional week is calculated by dividing the fourth quarter reported Sales, excluding legal contingency accruals recognized as a reduction to Sales that were not impacted by the additional week, by 14 weeks. We believe Adjusted Sales is a useful measure as it improves period-to-period comparability of sales when a fiscal year includes a 53-week accounting cycle.

Segment Operating Income (Loss) is defined as Operating Income (Loss) excluding corporate expenses and amortization. Corporate expenses are unallocated general and administrative costs, including the costs of corporate functions, that are shared across multiple segments. Amortization includes amortization from intangible assets, including brands and trademarks, customer relationships, supply arrangements, patents and intellectual property and land use rights, as well as amortization of software.

Segment Operating Income (Loss), As Adjusted is defined as Segment Operating Income (Loss) excluding items affecting comparability, which in management's judgment, affect the period-to-period assessment of operating results. Items affecting comparability include restructuring and related charges (including network optimization), plant closure and disposal charges (net of gains), goodwill and intangible impairments, brand and product line discontinuations, facility fire related costs (net of insurance proceeds) and certain non-ordinary course legal, regulatory and other matters, as well as the impact of an additional week in fiscal 2026.

Corporate Expenses, As Adjusted is defined as Corporate Expenses excluding items affecting comparability, which in management's judgment, affect the period-to-period assessment of operating results. Items affecting comparability include restructuring and related charges (including network optimization), corporate asset disposal charges (net of gains) and certain non-ordinary course legal, regulatory and other matters, as well as the impact of an additional week in fiscal 2026.

Amortization, As Adjusted is defined as Amortization excluding the impact of items affecting comparability, which in management's judgment, affect the period-to-period assessment of operating results. Items affecting comparability include accelerated amortization related to the discontinuance of intangible assets, as well as the impact of an additional week in fiscal 2026.

Free Cash Flow is defined as Cash Provided by Operating Activities minus payments for Property, Plant and Equipment.

GAAP Results to Non-GAAP Results Reconciliations (In millions, except per share data)

(Unaudited)

Results for the fourth quarter ended October 3, 2026

Sales

Cost of Sales

Selling,

General and Goodwill Administrative Impairment

Operating Income

Other Expense

Income (Loss) Income Tax Net Income (Loss)

before Income Expense Attributable to Taxes (Benefit) Tyson

EPS

Impact

GAAP Results

$ 1

$ (83) $

(16) $

(74) $

(0.22)

Restructuring and related charges

-

254

-

- 254

6

260

64

196

0.56

Legal contingency accruals9

110

14

-

- 124

-

124

28

96

0.28

Executive leadership transition charges10

-

-

10

- 10

-

10

-

10

0.03

Impact of antidilutive securities6

-

-

-

- -

-

-

-

-

0.01

Adjusted Non-GAAP Results prior to adjustment for additional week

$ 389

$ 311

$ 76

$ 228

$ 0.66

Less: Impact of additional week7

(1,049)

984

37

- (28)

6

(22)

(6)

(16)

(0.05)

Adjusted Non-GAAP Results $ 361 $ 289 $ 70 $ 212 $ 0.61

Results for the fourth quarter ended September 27, 2025

Sales

Cost of Sales

Selling,

General and Goodwill Administrative Impairment

Operating Income

Other

(Income) Expense

Income before Income Taxes

Income Tax Expense

Net Income

Attributable to Tyson

EPS

Impact

GAAP Results

$ 158

$ 68

$ 10

$ 47

$ 0.13

Facility fire related costs (insurance

proceeds)11

-

(4)

-

- (4)

(11)

(15)

(3)

(12)

(0.04)

Brand and product line discontinuations

-

-

6

- 6

-

6

2

4

0.01

Restructuring and related charges

-

12

-

- 12

-

12

-

12

0.03

Legal contingency accruals9

355

40

-

- 395

-

395

94

301

0.85

Product recall

66

(25)

-

- 41

-

41

11

30

0.09

Impairment of equity investments

-

-

-

- -

28

28

1

27

0.08

Adjusted Non-GAAP Results

$ 608

$ 535

$ 115

$

409

$ 1.15

Results for the twelve months ended October 3, 2026

Sales

Cost of Sales

Selling,

General and Goodwill Administrative Impairment

Operating Income

Other Expense

Income before Income Taxes

Income Tax Expense

Net Income

Attributable to Tyson

EPS

Impact

GAAP Results

$ 1,100

$ 669

$ 196

$ 453

$ 1.28

Restructuring and related charges

-

415

14

- 429

26

455

113

342

0.97

Legal contingency accruals9

358

35

-

- 393

-

393

93

300

0.85

Impairment of equity investments

Executive leadership transition

-

-

-

- -

73

73

19

54

0.15

charges10

-

-

83

-

83

-

83 -

83 0.24

Adjusted Non-GAAP Results prior to adjustment for additional week

$ 2,005

$ 1,673 $ 421

$ 1,232 $ 3.49

Less: Impact of additional week7

(1,049)

984

37

-

(28)

6

(22) (6)

(16) (0.05)

Adjusted Non-GAAP Results

$ 1,977

$ 1,651 $ 415

$ 1,216 $ 3.44

Results for the twelve months ended September 27, 2025

Sales

Cost of Sales

Selling,

General and Goodwill Administrative Impairment

Operating Income

Other

(Income) Expense

Income before Income Taxes

Income Tax Expense

Net Income

Attributable to Tyson

EPS

Impact

GAAP Results

$ 1,098

$ 769

$ 262

$ 474

$ 1.33

Facility fire related costs (insurance

proceeds)11

-

(18)

-

-

(18)

(18)

(36)

4

(40)

(0.12)

Brand and product line discontinuations

-

-

23

-

23

-

23

6

17

0.05

Restructuring and related charges

-

43

2

-

45

-

45

4

41

0.11

Legal contingency accruals9

698

40

-

-

738

-

738

175

563

1.58

Plant closure and disposal charges12

-

17

-

-

17

-

17

5

13

0.04

Goodwill and intangible impairments

-

-

-

343

343

-

343

-

343

0.96

Product recall

66

(25)

-

-

41

-

41

11

30

0.09

Impairment of equity investments

-

-

-

-

-

28

28

1

27

0.08

Adjusted Non-GAAP Results

$ 2,287

$ 1,968

$ 468

$ 1,468

$ 4.12

6 Certain potentially dilutive securities were excluded from the calculation of Net Income (Loss) Per Share Attributable to Tyson (GAAP EPS), because their inclusion would have been antidilutive due to the Company's net loss for the fourth quarter ended October 3, 2026. Because Adjusted EPS (non-GAAP) reflects net income, these securities are included in the diluted weighted average shares used to calculate Adjusted EPS.

Segment Operating Income (Loss), As Adjusted and Adjusted Operating Income (Loss) Non-GAAP Reconciliations (In millions)

(Unaudited)

Results for the fourth quarter ended October 3, 2026

Segment Operating Income (Loss)

Operating Income (Loss)

Beef

Pork Chicken

Prepared Foods

International

Total

Corporate Amortiza Expenses -tion

Total

As Reported

$ (514) $

(14) $ 405

$ 344

$ 52

$ 273

$ (214) $

(58) $

1

Add: Restructuring and related charges

230

21 -

2

1

254

-

-

254

Add: Legal contingency accruals9

100

10 14

-

-

124

-

-

124

Add: Executive leadership transition charges10

-

- -

-

-

-

10

-

10

As Adjusted prior to adjustment for additional week

$ (184) $

17 $ 419

$ 346

$ 53

$ 651

$ (204) $

(58) $

389

Less: Impact of additional week7

13

(1) (30)

(25)

(4)

(47)

15

4

(28)

As Adjusted

$ (171) $

16 $ 389

$ 321

$ 49

$ 604

$ (189) $

(54) $

361

Results for the fourth quarter ended September 27, 2025

Segment Operating Income (Loss)

Operating Income (Loss)

Beef

Pork Chicken

Prepared Foods

International

Total

Corporate Amortiza Expenses -tion

Total

As Reported

$ (277) $

(83) $ 558

$ 232

$ 1

$ 431

$ (209) $

(64) $

158

Less: Facility fire related costs (insurance proceeds)11

-

- -

-

(4)

(4)

-

-

(4)

Add: Brand and product line discontinuations

-

- -

-

-

-

-

6

6

Add: Restructuring and related charges

-

- 4

5

3

12

-

-

12

Add: Legal contingency accruals9

225

130 -

-

40

395

-

-

395

Add: Product recall

-

- -

41

-

41

-

-

41

As Adjusted

$ (52) $

47 $ 562

$ 278

$ 40

$ 875

$ (209) $

(58) $

608

Results for the twelve months ended October 3, 2026

Segment Operating Income (Loss)

Operating Income (Loss)

Beef

Pork

Chicken

Prepared Foods

International

Total

Corporate Amortiza Expenses -tion

Total

As Reported

$ (1,215) $

137

$ 1,749

$ 1,326

$ 179

$ 2,176

$ (856) $

(220) $

1,100

Add: Restructuring and related charges

358

22

12

31

-

423

6

-

429

Add: Legal contingency accruals9

190

70

128

-

5

393

-

-

393

Add: Executive leadership transition charges10

-

-

-

-

-

-

83

-

83

As Adjusted prior to adjustment for additional week

$ (667) $

229

$ 1,889

$ 1,357

$ 184

$ 2,992

$ (767) $

(220) $

2,005

Less: Impact of additional week7

13

(1)

(30)

(25)

(4)

(47)

15

4

(28)

As Adjusted

$ (654) $

228

$ 1,859

$ 1,332

$ 180

$ 2,945

$ (752) $

(216) $

1,977

Results for the twelve months ended September 27, 2025

Segment Operating Income (Loss)

Operating Income (Loss)

Beef

Pork Chicken

Prepared Foods

International

Total

Corporate Amortiza Expenses -tion

Total

As Reported

$ (984) $

(141) $ 1,860

$ 1,248

$ 155

$ 2,138

$ (783) $

(257) $

1,098

Less: Facility fire related costs (insurance proceeds)11

-

- -

-

(18)

(18)

-

-

(18)

Add: Brand and product line discontinuations

-

- -

-

-

-

-

23

23

Add/(Less): Restructuring and related charges (gain)

48

- 9

(26)

14

45

-

-

45

Add: Legal contingency accruals9

318

380 -

-

40

738

-

-

738

Add/(Less): Plant closure and disposal charges12

-

- 23

-

(6)

17

-

-

17

Add: Goodwill and intangible impairments

343

- -

-

-

343

-

-

343

Add: Product recall

-

- -

41

-

41

-

-

41

As Adjusted

$ (275) $

239 $ 1,892

$ 1,263

$ 185

$ 3,304

$ (783) $

(234) $

2,287

Tyson Foods, Inc. on 6ix

In the deck

Story so far

Earlier from Tyson Foods

Later from Tyson Foods

All Tyson Foods news releases